Sol Langermann
Chief Scientific Officer at NextCure, Inc. (NXTC)
Sol Langermann has filed 6 insider reports with the SEC since March 2021, as chief Scientific Officer at NextCure, Inc. (NXTC). The latest filing, on February 3, 2025, reports grant or award at NextCure, Inc. (NXTC).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Sol Langermann is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | $6.45 | Feb 3, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 31, 2025NXTCSEC Form 4 filed by Chief Scientific Officer Langermann SolForm 4Grant or award
- Mar 29, 2024NXTCSEC Form 4 filed by Langermann SolForm 4Grant or award
- Jan 31, 2024NXTCSEC Form 4 filed by Langermann SolForm 4Grant or award
- Feb 28, 2023NXTCSEC Form 4 filed by Langermann SolForm 4Grant or award
- Jan 31, 2022NXTCSEC Form 4 filed by Langermann SolForm 4Grant or award
- Mar 15, 2021NXTCSEC Form 4 filed by Sol LangermannForm 4Grant or award
Compare Sol Langermann with
- Sol Langermann vs Anne Elizabeth Borgman1 shared
- Sol Langermann vs Elaine V Jones1 shared
- Sol Langermann vs Ellen Feigal1 shared
- Sol Langermann vs David S Kabakoff1 shared
- Sol Langermann vs Stephen W Webster1 shared
- Sol Langermann vs John G Houston1 shared
Other insiders at the same companies
- ADAR1 Capital Management, LLCNXTC
- Simcere Zaiming, Inc.NXTC
- Anne Elizabeth BorgmanNXTC
- Elaine V JonesNXTC
- Ellen FeigalNXTC
- Stephen W WebsterNXTC
- David S KabakoffNXTC
- John G HoustonNXTC
- Kevin G. ShawNXTC
- Sourav KunduNXTC
- Michael RichmanNXTC
- Steven P. CobournNXTC
- Timothy MayerNXTC
- Udayan GuhaNXTC
Questions about Sol Langermann
- What is Sol Langermann's role at NextCure, Inc.?
- Sol Langermann reports to the SEC as chief Scientific Officer at NextCure, Inc. (NXTC), according to the latest filing on February 3, 2025.
- Has Sol Langermann bought or sold stock recently?
- No open-market purchases or sales by Sol Langermann are on file. The filings report grant or award.
- How do I get alerts when Sol Langermann files?
- Follow Sol Langermann on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Sol Langermann (SEC CIK 0001775459). Totals count each trade once, skipping amendments whose original is on file, from Mar 16, 2021 on. View on SEC EDGAR · Get this as JSON